Adage Capital Partners Portfolio holdings
AUM
$59.3B
This Quarter Return
+10.77%
1 Year Return
+26.26%
3 Year Return
+130.73%
5 Year Return
+248.99%
10 Year Return
+658.76%
AUM
$55.5B
AUM Growth
+$55.5B
(+9.4%)
Cap. Flow
+$535M
Cap. Flow
% of AUM
0.96%
Top 10 Holdings %
Top 10 Hldgs %
23.64%
Holding
1,156
New
140
Increased
289
Reduced
382
Closed
138
Top Buys
| 1 |
GE Aerospace
GE
|
$266M |
| 2 |
Dollar Tree
DLTR
|
$251M |
| 3 |
Burlington
BURL
|
$211M |
| 4 |
Tesla
TSLA
|
$153M |
| 5 |
Carrier Global
CARR
|
$139M |
Top Sells
| 1 |
XEC
CIMAREX ENERGY CO
XEC
|
$625M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$189M |
| 3 |
Northrop Grumman
NOC
|
$166M |
| 4 |
Johnson & Johnson
JNJ
|
$131M |
| 5 |
General Dynamics
GD
|
$126M |
Sector Composition
| 1 | Technology | 23.75% |
| 2 | Healthcare | 15.7% |
| 3 | Financials | 13.31% |
| 4 | Consumer Discretionary | 11.56% |
| 5 | Industrials | 8.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
176
Southern Company
SO
$102B
| $63.7M | 0.11% |
929,300
-95,300
| -9% | -$6.54M |
|
177
Humana
HUM
$36.5B
| $63.6M | 0.11% |
137,010
-900
| -0.7% | -$417K |
|
178
Flywire
FLYW
$1.61B
| $63.3M | 0.11% |
1,663,149
+338,340
| +26% | +$12.9M |
|
179
Autodesk
ADSK
$67.3B
| $63.1M | 0.11% |
224,289
+21,800
| +11% | +$6.13M |
|
180
Colgate-Palmolive
CL
$67.9B
| $62.8M | 0.11% |
735,672
-117,700
| -14% | -$10M |
|
181
Nova
NVMI
$7.74B
| $62.6M | 0.11% |
427,272
-535,222
| -56% | -$78.4M |
|
182
Ecolab
ECL
$78.6B
| $62.3M | 0.11% |
265,625
-71,000
| -21% | -$16.7M |
|
|
ABMD
183
DELISTED
Abiomed Inc
ABMD
| $62.3M | 0.11% |
173,443
+125,100
| +259% | +$44.9M |
|
184
Capital One
COF
$145B
| $62M | 0.11% |
427,474
-133,900
| -24% | -$19.4M |
|
185
Vulcan Materials
VMC
$38.5B
| $61.8M | 0.11% |
297,580
-249,454
| -46% | -$51.8M |
|
186
KLA
KLAC
$115B
| $61.5M | 0.11% |
143,070
-8,000
| -5% | -$3.44M |
|
187
Public Storage
PSA
$51.7B
| $60.9M | 0.11% |
162,592
-900
| -0.6% | -$337K |
|
188
Regeneron Pharmaceuticals
REGN
$61.5B
| $60.4M | 0.11% |
95,649
+165
| +0.2% | +$104K |
|
189
Lightspeed Commerce
LSPD
$1.67B
| $59.5M | 0.11% |
1,472,528
+1,149,533
| +356% | +$46.5M |
|
190
Teradyne
TER
$18.8B
| $59.3M | 0.11% |
362,924
-46,200
| -11% | -$7.56M |
|
191
Ultragenyx Pharmaceutical
RARE
$2.89B
| $58.9M | 0.11% |
700,000
+80,000
| +13% | +$6.73M |
|
192
Novo Nordisk
NVO
$251B
| $58.8M | 0.11% |
+525,000
| New | +$58.8M |
|
193
Sarepta Therapeutics
SRPT
$1.78B
| $58.5M | 0.11% |
650,000
+250,000
| +63% | +$22.5M |
|
194
Bank of New York Mellon
BK
$74.5B
| $58.4M | 0.11% |
1,006,016
+149,300
| +17% | +$8.67M |
|
195
Synopsys
SNPS
$112B
| $58M | 0.1% |
157,500
+3,900
| +3% | +$1.44M |
|
196
IQVIA
IQV
$32.4B
| $57.4M | 0.1% |
203,600
-1,600
| -0.8% | -$451K |
|
197
Otis Worldwide
OTIS
$33.9B
| $57.2M | 0.1% |
657,243
-172,661
| -21% | -$15M |
|
198
Fox Class A
FOXA
$26.6B
| $56.9M | 0.1% |
1,541,519
+444,935
| +41% | +$16.4M |
|
199
GitLab
GTLB
$7.93B
| $56.7M | 0.1% |
+651,785
| New | +$56.7M |
|
200
Charter Communications
CHTR
$36.3B
| $56.6M | 0.1% |
86,847
+56,025
| +182% | +$36.5M |
|